Here, we concentrated on exploring the immunotherapeutic potential of Vγ9Vδ2 T-cells since they were selectively depleted in HCC but can be readily expanded in vitro, have a well-defined tumour ligand in the form of IPP and showed the capacity to acquire TRM features. The gene discussed is IPP; the disease is neoplasm.